Out-licensing

Messenger Biopharma will not develop its own mRNA products.

We are eager to out-license our Aegis biotechnology to pharmaceutical and biotech companies for vaccine and gene therapy products development.

Last news

photo labo 5

Messenger Biopharma hires an animal experimenter

posted February 27, 2017

Messenger Biopharma is seeking a ...Read More